Enhanced organizational structure will drive innovation and improve engagement with and delivery of excellence to KARL STORZ customers, accelerating growth
EL SEGUNDO, Calif.–(BUSINESS WIRE)–KARL STORZ, a leading family-owned medical technology company, today announced it will centralize management of its United States organizations, including its research and development, manufacturing, and commercial operations, to bring more innovative products to market worldwide with greater speed. Sonal Matai, who has led the US commercial business for two years, has been named President of KARL STORZ in the United States and will lead the effort to bring this ambitious transformation to life.
“The US is the world’s largest medical device market and also the largest market for KARL STORZ,” said Sonal Matai, US President of KARL STORZ. “Our 2,700 employees in the United States can now work together more closely to create an enhanced customer experience in this critical geography through innovative products and superior service.”
“Our new organizational structure will bring benefits to all our stakeholders. Our suppliers and vendor partners will benefit from streamlined interactions with an integrated KARL STORZ in the US,” Matai added.
Matai was previously Managing Director, KARL STORZ Endoscopy-America, Inc. In that role, he spearheaded a period of significant innovation and market share expansion. His prior leadership experiences at large MedTech companies and start-ups, as well as his global outlook and dedication to innovation and customer satisfaction, have honed his ability to drive progress and steer market leadership.
About KARL STORZ
KARL STORZ United States is a leader in endoscopic technology and imaging solutions across virtually all surgical specialties. It is a subsidiary of KARL STORZ SE & Co. KG, an international medical technology company that is family-owned and based in Tuttlingen, Germany. KARL STORZ stands for visionary design, precision craftsmanship, and clinical effectiveness and has a portfolio that includes more than 15,000 products for human and veterinary medicine.
Contacts
MEDIA CONTACT:
Susan Mancia
Director, Integrated Marketing Communications
KARL STORZ United States
Phone: 562-841-1515
Email: susan.mancia@karlstorz.com
Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…
Key Trends, Vendor Performance, and Opportunities Transforming Mexico's Healthcare IT Landscape MIAMI, FLORIDA / ACCESSWIRE…
Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or…
DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…
PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused…